Atrion (ATRI) has a profit margin of 6.91%, below the Healthcare sector average of 15.58%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2024
Trailing 12 months ending Jun 2024
The latest profit margin for ATRI is 6.91% as of June 2024. That compares with 15.88% in the prior-year period — down 56.5% year over year. That is below the Healthcare sector average of 15.58%. Investors often review this figure alongside Atrion's historical trend and sector peers before judging valuation or financial health.
Over the past year, ATRI's profit margin moved from 15.88% to 6.91% — a 56.5% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Atrion's valuation or profitability profile.
Against Healthcare companies, ATRI currently prints 6.91% for profit margin, while the sector average sits near 15.58%. That is roughly 55.6% below the sector mean. Large gaps often invite a closer look at Atrion's growth, margins, and balance sheet.
Profit Margin shows how effectively Atrion converts resources into returns. At 6.91%, ATRI may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 15.88% in the prior-year period — down 56.5% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting ATRI's profit margin (6.91%), review year-over-year change from 15.88%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.